Industry: Healthcare | Publish Date: 02-Sep-2020 | No of Pages: 675 | No. of Tables: 399 | No. of Figures: 370 | Format: PDF | Report Code : N/A
The global Electrocardiograph (ECG) Market size valued to USD 5.37 billion in 2019, is predicted to garner USD 8.87 billion by 2030, with a CAGR of 4.60% from 2020-2030.
Electrocardiograph is a non-invasive medical test that represents the electrical activity of the heart over a time span. In this test electrodes are placed on the skin to give a graph of voltage versus time; detecting the small electrical changes occurring due to depolarization and repolarization of the cardiac muscle during each cardiac cycle. Changes in the normal ECG pattern occur in numerous cardiac abnormalities such as cardiac rhythm disturbances, inadequate coronary artery blood flow, and electrolyte disturbances.
The global electrocardiograph (ECG) market has witnessed a substantial growth in past few years and is expected to grow at a considerable rate throughout the forecast period, owing to constantly multiplying incidences of casualties due to Cardiovascular Diseases (CVDs). According to the World Health Organization, more than 17.9 million died of Cardiovascular diseases in the year 2016, world-wide. This scenario augments the demand for advanced healthcare facilities offering proper diagnosis, treatment and monitoring of CVDs, hence propagating the market growth.
Besides, factors such as advancements in ECG technologies, a growing number of geriatric populations, and development in healthcare infrastructures, are anticipated in supplementing the market growth throughout the forecast period. Furthermore, the behavioural risk factors such as tobacco consumption, unhealthy food-habits, obesity issues, physical inactivity and alcohol consumption at individual level, are expected to bring an upsurge in the global electrocardiograph (ECG) market, in coming future.
However, cost-effectiveness of premium ECG devices, unfavourable reimbursement policies, and increase in market saturation specifically in the North-America region, are the factors responsible in hampering the electrocardiograph (ECG) market growth during the forecast period.
Moreover, factors such as favourable government initiatives for public welfare, increase in R&D activities and new product launches by the market players, as well as introduction of remote monitoring devices for comprehensive ECG monitoring, are expected to create ample of growth opportunities in the global market in coming future.
The electrocardiograph (ECG) market share analysis is based on product, lead type, end user, and geography.
Based on product, the market is segmented into resting ECG, stress ECG, holter monitors. Based on lead type, the market is segmented into the single lead, 3-6 lead, and 12-lead. Based on the end user, the market is segmented into hospitals & clinics, home settings & ambulatory surgical centers (ASCs), and others. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
Asia-Pacific region denotes a higher adoption of the electrocardiograph (ECG) and is anticipated to hold the highest market share in the electrocardiograph (ECG) market, during the forecast period. This is attributable to the factors including the increase in developments in the healthcare system, increasing disposable income, favorable government policies, high population base, and large untapped potential market in this region.
North America region would witness increasing market size in the global market, owing to the presence of well-established healthcare facilities, high consumer awareness, and technological advancements.
Comprehensive competitive analysis and profiles of the major market players such as OSI Systems Fukuda Denshi Co Ltd., Opto Circuits Limited, Philips Healthcare, Schiller Ag, General Electric Company, Johnson and Johnson, Mortara Instrument, Inc, Medtronic Plc, Mindray Medical International Limited and others are provided in the electrocardiograph (ECG) industry report.
An upsurge in R&D activities and advancement in product technology with new product launches by the key players, is leading the healthcare infrastructure to new heights, by creating lucrative opportunities for the global electrocardiograph (ECG) market.
For instance, in February 2020, one of the major market players in the global market, Johnson and Johnson, in collaboration with Apple, launched its first ever virtual study app ‘Heartline’ on iPhone, along with the ECG app and irregular rhythm notification feature on the Apple Watch. The ‘Heartline’ is a study that showcases on how digital health tools, like the ECG app and irregular rhythm notification feature on Apple Watch, could lead to earlier detection of atrial fibrillation, helping patients get more aware about their heart health, and improving health outcomes.
The electrocardiograph (ECG) market report provides a quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on.
The study comprises a deep dive analysis of the global market including current and future trends for depicting the prevalent investment pockets in the market
The report provides detailed information related to key drivers, restraints, opportunities and their impact on the market.
The report incorporates a competitive analysis of the market players along with their market share and market size in the global market.
The study elaborates SWOT analysis and Porters Five Forces model along with the market trend analysis.
Value chain analysis in the electrocardiograph (ECG) market study provides a clear picture of the stakeholders’ roles.
Resting ECG
Stress ECG
Holter Monitors
Single Lead
3-6 Lead
12-Lead
Hospitals & Clinics
Home Settings & Ambulatory Surgical Centers (ASCs)
Others
North America
U.S
Canada
Mexico
Europe
UK
Germany
France
Spain
Italy
Netherlands
Denmark
Finland
Norway
Sweden
Russia
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Singapore
Taiwan
Thailand
Rest of Asia-Pacific
RoW
Latin America
Middle East
Africa
Report Scope and Segmentation
Parameters |
Details |
Analysis Period |
2019–2030 |
Base Year Considered |
2020 |
Forecast Period |
2020–2030 |
Market Size Estimation |
Billion (USD) |
Market Segmentation |
By Product (Resting ECG, Stress ECG, Holter Monitors) By Lead Type (Single Lead, -6 Lead, -Lead) By End User (Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers (ASCs), Other End Users) |
Countries Covered |
28 |
Companies Profiled |
OSI Systems Fukuda Denshi Co Ltd., Opto Circuits Limited, Philips Healthcare, Schiller Ag, General Electric Company, Johnson and Johnson, Mortara Instrument, Inc, Medtronic Plc, Mindray Medical International Limited |
Nihon Kohden Corporation
OSI Systems Fukuda Denshi Co Ltd.
Opto Circuits Limited
Philips Healthcare
Schiller AG
General Electric Company
Johnson and Johnson
Mortara Instrument, Inc
Medtronic Plc
Mindray Medical International Limited